Share Price and Basic Stock Data
Last Updated: October 29, 2025, 6:44 am
| PEG Ratio | 1.16 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Lumax Industries Ltd operates in the auto ancillary sector, specializing in equipment lamps. As of October 2023, the company’s stock price stood at ₹5,009, with a market capitalization of ₹4,683 Cr. In the fiscal year ending March 2023, Lumax reported sales of ₹2,320 Cr, marking a notable increase from ₹1,751 Cr in FY 2022. This upward trajectory continued with sales projected at ₹2,637 Cr for FY 2024 and an ambitious ₹3,400 Cr for FY 2025. Quarterly sales trends reveal consistent growth, with Q1 FY 2024 sales recorded at ₹618 Cr, rising to ₹766 Cr in Q2 FY 2025. This growth reflects the company’s robust demand in a recovering automotive market post-pandemic, aligning with broader industry trends in India, where vehicle production has seen a revival. The company’s ability to maintain growth amidst fluctuating economic conditions showcases its operational resilience and market relevance.
Profitability and Efficiency Metrics
Lumax Industries demonstrated solid profitability metrics, with a net profit of ₹142 Cr in the trailing twelve months, reflecting a net profit margin of 1.91%. The operating profit margin (OPM) stood at 9%, consistent with the industry average. Quarterly data indicates a healthy operating profit of ₹66 Cr in Q4 FY 2024, with a further increase to ₹79 Cr in Q1 FY 2025. The company’s return on equity (ROE) was recorded at 19.3%, indicating effective utilization of shareholder funds. Efficiency metrics also highlight a cash conversion cycle (CCC) of -6 days, which is favorable compared to typical industry standards, suggesting that Lumax effectively manages its receivables and inventories. However, the inventory days have increased, reflecting potential challenges in inventory management, which could affect liquidity if not addressed. Overall, Lumax’s profitability ratios and operational efficiencies position it favorably within the auto ancillary sector.
Balance Sheet Strength and Financial Ratios
Lumax Industries’ balance sheet reflects a solid financial foundation, with total assets amounting to ₹2,861 Cr as of March 2025, against total liabilities of ₹2,861 Cr, indicating a balanced structure. The company reported reserves of ₹765 Cr, enhancing its equity base and providing a buffer for future investments. However, total borrowings have increased to ₹888 Cr, resulting in a debt-to-equity ratio of 0.99, which is on the higher side compared to industry norms. The interest coverage ratio (ICR) stood at 3.99x, suggesting that Lumax can comfortably meet its interest obligations, though a declining trend in this ratio may warrant attention. The price-to-book value (P/BV) ratio of 3.05x indicates that the market values Lumax’s equity at a premium, reflecting investor confidence. Overall, while the balance sheet shows strength, the rising debt levels require careful monitoring to ensure sustainable growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Lumax Industries reveals a strong promoter holding of 75%, which indicates significant control and commitment from the founding family. This stability is further supported by a gradual increase in institutional investments, with Foreign Institutional Investors (FIIs) holding 1.13% and Domestic Institutional Investors (DIIs) at 5.98%. The public shareholding stands at 17.89%, with a total of 21,486 shareholders as of September 2025. The steady increase in DII holdings, particularly from 0.57% in December 2022 to 5.75% in March 2025, reflects growing institutional confidence in the company’s future prospects. However, the relatively low FII participation may indicate cautious sentiment among foreign investors towards the auto ancillary sector. This blend of ownership structures could provide Lumax with both stability and the potential for strategic growth initiatives, bolstering investor confidence moving forward.
Outlook, Risks, and Final Insight
Looking ahead, Lumax Industries is positioned to benefit from the ongoing recovery in the automotive sector, with projected sales growth providing a favorable outlook. However, challenges such as rising input costs and potential supply chain disruptions could pose risks to profitability. Additionally, the increasing debt levels necessitate careful management to avoid compromising financial stability. Strengths such as a solid ROE of 19.3% and a strong promoter holding position Lumax favorably in the competitive landscape. Conversely, the rising inventory days and higher debt-to-equity ratio present areas of concern that require strategic attention. Overall, Lumax’s established market presence and growth trajectory, coupled with a proactive approach to risk management, could enable it to navigate future challenges effectively, enhancing shareholder value in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Lumax Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 9,281 Cr. | 607 | 666/365 | 49.2 | 102 | 0.16 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 271 Cr. | 238 | 588/213 | 116 | 41.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 4,683 Cr. | 5,009 | 5,358/1,960 | 33.0 | 828 | 0.70 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,534 Cr. | 2,103 | 2,276/1,156 | 26.3 | 394 | 1.43 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 4,942.25 Cr | 1,989.25 | 56.13 | 341.30 | 0.57% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 512 | 620 | 579 | 608 | 618 | 644 | 632 | 743 | 766 | 816 | 887 | 923 | 923 |
| Expenses | 469 | 560 | 524 | 559 | 567 | 589 | 573 | 677 | 708 | 755 | 817 | 844 | 841 |
| Operating Profit | 43 | 60 | 56 | 49 | 51 | 55 | 58 | 66 | 58 | 61 | 70 | 79 | 82 |
| OPM % | 8% | 10% | 10% | 8% | 8% | 9% | 9% | 9% | 8% | 8% | 8% | 9% | 9% |
| Other Income | 9 | 15 | 13 | 14 | 14 | 15 | 13 | 28 | 31 | 21 | 18 | 25 | 16 |
| Interest | 6 | 7 | 8 | 9 | 10 | 11 | 13 | 15 | 16 | 19 | 19 | 18 | 18 |
| Depreciation | 19 | 20 | 20 | 21 | 21 | 21 | 24 | 27 | 26 | 26 | 27 | 33 | 32 |
| Profit before tax | 27 | 48 | 41 | 33 | 34 | 38 | 35 | 52 | 46 | 37 | 42 | 53 | 48 |
| Tax % | 28% | 31% | 27% | 38% | 32% | 31% | 27% | 31% | 26% | 23% | 19% | 18% | 25% |
| Net Profit | 20 | 33 | 30 | 21 | 23 | 26 | 26 | 36 | 34 | 28 | 33 | 44 | 36 |
| EPS in Rs | 21.20 | 35.27 | 31.60 | 22.20 | 24.73 | 28.08 | 27.37 | 38.59 | 36.57 | 30.25 | 35.82 | 47.04 | 38.72 |
Last Updated: August 20, 2025, 7:40 am
Below is a detailed analysis of the quarterly data for Lumax Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 923.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 923.00 Cr..
- For Expenses, as of Jun 2025, the value is 841.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 844.00 Cr. (Mar 2025) to 841.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 82.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00%.
- For Other Income, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 18.00% (Mar 2025) to 25.00%, marking an increase of 7.00%.
- For Net Profit, as of Jun 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2025) to 36.00 Cr., marking a decrease of 8.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 38.72. The value appears to be declining and may need further review. It has decreased from 47.04 (Mar 2025) to 38.72, marking a decrease of 8.32.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:56 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,252 | 1,271 | 1,649 | 1,851 | 1,602 | 1,426 | 1,751 | 2,320 | 2,637 | 3,400 | 3,549 |
| Expenses | 1,164 | 1,170 | 1,515 | 1,698 | 1,443 | 1,326 | 1,616 | 2,112 | 2,405 | 3,120 | 3,257 |
| Operating Profit | 89 | 101 | 135 | 154 | 158 | 100 | 135 | 208 | 231 | 280 | 292 |
| OPM % | 7% | 8% | 8% | 8% | 10% | 7% | 8% | 9% | 9% | 8% | 8% |
| Other Income | 4 | 17 | 19 | 57 | 19 | 27 | 3 | 51 | 70 | 84 | 80 |
| Interest | 13 | 11 | 8 | 16 | 22 | 29 | 22 | 30 | 49 | 73 | 74 |
| Depreciation | 38 | 41 | 48 | 60 | 64 | 65 | 64 | 80 | 93 | 113 | 119 |
| Profit before tax | 41 | 65 | 98 | 134 | 92 | 33 | 53 | 149 | 159 | 178 | 180 |
| Tax % | 10% | 16% | 27% | 23% | 22% | 45% | 23% | 31% | 30% | 21% | |
| Net Profit | 52 | 54 | 71 | 104 | 72 | 18 | 41 | 103 | 111 | 140 | 142 |
| EPS in Rs | 55.66 | 58.16 | 76.34 | 111.03 | 76.92 | 19.42 | 43.56 | 110.27 | 118.77 | 149.67 | 151.83 |
| Dividend Payout % | 22% | 25% | 30% | 32% | 31% | 36% | 31% | 24% | 29% | 23% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.85% | 31.48% | 46.48% | -30.77% | -75.00% | 127.78% | 151.22% | 7.77% | 26.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.64% | 15.00% | -77.25% | -44.23% | 202.78% | 23.44% | -143.45% | 18.36% |
Lumax Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 25% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 38% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 22% |
| 3 Years: | 37% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 19% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 9:55 am
Balance Sheet
Last Updated: June 16, 2025, 11:47 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 259 | 300 | 353 | 426 | 437 | 451 | 482 | 574 | 662 | 765 |
| Borrowings | 127 | 92 | 104 | 140 | 347 | 338 | 401 | 431 | 723 | 888 |
| Other Liabilities | 463 | 478 | 751 | 615 | 490 | 564 | 654 | 852 | 1,207 | 1,199 |
| Total Liabilities | 859 | 880 | 1,217 | 1,190 | 1,283 | 1,362 | 1,546 | 1,866 | 2,601 | 2,861 |
| Fixed Assets | 408 | 419 | 518 | 549 | 653 | 627 | 711 | 749 | 968 | 1,106 |
| CWIP | 17 | 20 | 34 | 50 | 32 | 47 | 48 | 43 | 178 | 212 |
| Investments | 69 | 79 | 88 | 81 | 90 | 92 | 102 | 147 | 179 | 246 |
| Other Assets | 365 | 362 | 577 | 510 | 508 | 596 | 685 | 927 | 1,276 | 1,297 |
| Total Assets | 859 | 880 | 1,217 | 1,190 | 1,283 | 1,362 | 1,546 | 1,866 | 2,601 | 2,861 |
Below is a detailed analysis of the balance sheet data for Lumax Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
- For Reserves, as of Mar 2025, the value is 765.00 Cr.. The value appears strong and on an upward trend. It has increased from 662.00 Cr. (Mar 2024) to 765.00 Cr., marking an increase of 103.00 Cr..
- For Borrowings, as of Mar 2025, the value is 888.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 723.00 Cr. (Mar 2024) to 888.00 Cr., marking an increase of 165.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,199.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,207.00 Cr. (Mar 2024) to 1,199.00 Cr., marking a decrease of 8.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,861.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,601.00 Cr. (Mar 2024) to 2,861.00 Cr., marking an increase of 260.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,106.00 Cr.. The value appears strong and on an upward trend. It has increased from 968.00 Cr. (Mar 2024) to 1,106.00 Cr., marking an increase of 138.00 Cr..
- For CWIP, as of Mar 2025, the value is 212.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2024) to 212.00 Cr., marking an increase of 34.00 Cr..
- For Investments, as of Mar 2025, the value is 246.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2024) to 246.00 Cr., marking an increase of 67.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,297.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,276.00 Cr. (Mar 2024) to 1,297.00 Cr., marking an increase of 21.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,861.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,601.00 Cr. (Mar 2024) to 2,861.00 Cr., marking an increase of 260.00 Cr..
However, the Borrowings (888.00 Cr.) are higher than the Reserves (765.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -38.00 | 9.00 | 31.00 | 14.00 | -189.00 | -238.00 | -266.00 | -223.00 | -492.00 | -608.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 55 | 70 | 44 | 39 | 55 | 48 | 48 | 48 | 50 |
| Inventory Days | 45 | 52 | 57 | 61 | 75 | 94 | 91 | 96 | 129 | 92 |
| Days Payable | 135 | 146 | 180 | 114 | 131 | 159 | 163 | 141 | 154 | 147 |
| Cash Conversion Cycle | -36 | -39 | -53 | -9 | -17 | -9 | -24 | 3 | 22 | -6 |
| Working Capital Days | -58 | -54 | -57 | -49 | -78 | -75 | -60 | -38 | -49 | -44 |
| ROCE % | 19% | 24% | 22% | 17% | 8% | 11% | 19% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Transportation and Logistics Fund | 37,000 | 1.86 | 10.29 | 37,000 | 2025-04-22 15:56:56 | 0% |
| HDFC Retirement Savings Fund - Hybrid Equity - Regular Plan | 32,000 | 0.6 | 8.9 | 32,000 | 2025-04-22 15:56:56 | 0% |
| Bank of India Manufacturing & Infrastructure Fund | 18,882 | 1.3 | 5.25 | 18,882 | 2025-04-22 15:56:56 | 0% |
| Bandhan Hybrid Equity Fund | 13,732 | 0.52 | 3.82 | 13,732 | 2025-04-22 14:36:32 | 0% |
| Bank of India Large & Mid Cap Equity Fund | 10,138 | 0.81 | 2.82 | 10,138 | 2025-04-22 15:56:56 | 0% |
| Bank of India Large & Mid Cap Equity Fund - Eco Plan | 10,138 | 0.81 | 2.82 | 10,138 | 2025-04-22 15:56:56 | 0% |
| Navi Large & Midcap Fund - Regular Plan | 7,500 | 0.67 | 2.09 | 7,500 | 2025-04-22 15:56:56 | 0% |
| HDFC Retirement Savings Fund - Hybrid Debt - Regular Plan | 1,500 | 0.27 | 0.43 | 1,500 | 2025-04-22 15:56:56 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| Diluted EPS (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| Cash EPS (Rs.) | 190.93 | 155.92 | 151.15 | 104.54 | 86.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 828.32 | 718.41 | 624.30 | 526.06 | 492.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 828.32 | 718.41 | 624.30 | 526.06 | 492.56 |
| Revenue From Operations / Share (Rs.) | 3637.68 | 2820.58 | 2481.38 | 1873.52 | 1525.49 |
| PBDIT / Share (Rs.) | 308.75 | 258.66 | 237.64 | 158.72 | 133.20 |
| PBIT / Share (Rs.) | 187.55 | 159.33 | 152.15 | 90.61 | 64.18 |
| PBT / Share (Rs.) | 110.23 | 108.11 | 114.93 | 49.37 | 33.72 |
| Net Profit / Share (Rs.) | 69.73 | 56.59 | 65.66 | 36.43 | 17.77 |
| NP After MI And SOA / Share (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| PBDIT Margin (%) | 8.48 | 9.17 | 9.57 | 8.47 | 8.73 |
| PBIT Margin (%) | 5.15 | 5.64 | 6.13 | 4.83 | 4.20 |
| PBT Margin (%) | 3.03 | 3.83 | 4.63 | 2.63 | 2.21 |
| Net Profit Margin (%) | 1.91 | 2.00 | 2.64 | 1.94 | 1.16 |
| NP After MI And SOA Margin (%) | 4.11 | 4.21 | 4.44 | 2.32 | 1.27 |
| Return on Networth / Equity (%) | 18.06 | 16.53 | 17.66 | 8.28 | 3.94 |
| Return on Capital Employeed (%) | 14.30 | 13.76 | 17.86 | 12.80 | 10.68 |
| Return On Assets (%) | 4.89 | 4.26 | 5.52 | 2.63 | 1.33 |
| Long Term Debt / Equity (X) | 0.27 | 0.22 | 0.10 | 0.11 | 0.00 |
| Total Debt / Equity (X) | 0.99 | 0.88 | 0.65 | 0.74 | 0.65 |
| Asset Turnover Ratio (%) | 1.25 | 1.18 | 1.42 | 1.24 | 1.11 |
| Current Ratio (X) | 0.75 | 0.79 | 0.78 | 0.69 | 0.63 |
| Quick Ratio (X) | 0.44 | 0.41 | 0.42 | 0.39 | 0.35 |
| Inventory Turnover Ratio (X) | 6.22 | 3.63 | 4.79 | 4.63 | 4.29 |
| Dividend Payout Ratio (NP) (%) | 23.38 | 22.73 | 12.24 | 16.06 | 30.89 |
| Dividend Payout Ratio (CP) (%) | 12.92 | 12.38 | 6.89 | 6.26 | 6.78 |
| Earning Retention Ratio (%) | 76.62 | 77.27 | 87.76 | 83.94 | 69.11 |
| Cash Earning Retention Ratio (%) | 87.08 | 87.62 | 93.11 | 93.74 | 93.22 |
| Interest Coverage Ratio (X) | 3.99 | 5.05 | 7.57 | 6.93 | 4.37 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.10 | 3.28 | 3.39 | 1.58 |
| Enterprise Value (Cr.) | 3121.11 | 2795.80 | 2030.76 | 1175.94 | 1796.46 |
| EV / Net Operating Revenue (X) | 0.91 | 1.06 | 0.87 | 0.67 | 1.26 |
| EV / EBITDA (X) | 10.81 | 11.56 | 9.14 | 7.93 | 14.43 |
| MarketCap / Net Operating Revenue (X) | 0.69 | 0.85 | 0.71 | 0.47 | 1.05 |
| Retention Ratios (%) | 76.61 | 77.26 | 87.75 | 83.93 | 69.10 |
| Price / BV (X) | 3.05 | 3.34 | 2.84 | 1.68 | 3.26 |
| Price / Net Operating Revenue (X) | 0.69 | 0.85 | 0.71 | 0.47 | 1.05 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.04 | 0.01 |
After reviewing the key financial ratios for Lumax Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For Diluted EPS (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 190.93. This value is within the healthy range. It has increased from 155.92 (Mar 24) to 190.93, marking an increase of 35.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 828.32. It has increased from 718.41 (Mar 24) to 828.32, marking an increase of 109.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 828.32. It has increased from 718.41 (Mar 24) to 828.32, marking an increase of 109.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,637.68. It has increased from 2,820.58 (Mar 24) to 3,637.68, marking an increase of 817.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 308.75. This value is within the healthy range. It has increased from 258.66 (Mar 24) to 308.75, marking an increase of 50.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 187.55. This value is within the healthy range. It has increased from 159.33 (Mar 24) to 187.55, marking an increase of 28.22.
- For PBT / Share (Rs.), as of Mar 25, the value is 110.23. This value is within the healthy range. It has increased from 108.11 (Mar 24) to 110.23, marking an increase of 2.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 69.73. This value is within the healthy range. It has increased from 56.59 (Mar 24) to 69.73, marking an increase of 13.14.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For PBDIT Margin (%), as of Mar 25, the value is 8.48. This value is below the healthy minimum of 10. It has decreased from 9.17 (Mar 24) to 8.48, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 5.15. This value is below the healthy minimum of 10. It has decreased from 5.64 (Mar 24) to 5.15, marking a decrease of 0.49.
- For PBT Margin (%), as of Mar 25, the value is 3.03. This value is below the healthy minimum of 10. It has decreased from 3.83 (Mar 24) to 3.03, marking a decrease of 0.80.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has decreased from 2.00 (Mar 24) to 1.91, marking a decrease of 0.09.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 8. It has decreased from 4.21 (Mar 24) to 4.11, marking a decrease of 0.10.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 16.53 (Mar 24) to 18.06, marking an increase of 1.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.30. This value is within the healthy range. It has increased from 13.76 (Mar 24) to 14.30, marking an increase of 0.54.
- For Return On Assets (%), as of Mar 25, the value is 4.89. This value is below the healthy minimum of 5. It has increased from 4.26 (Mar 24) to 4.89, marking an increase of 0.63.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.99. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 0.99, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.25. It has increased from 1.18 (Mar 24) to 1.25, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1.5. It has decreased from 0.79 (Mar 24) to 0.75, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 24) to 0.44, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 6.22, marking an increase of 2.59.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 23.38. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 23.38, marking an increase of 0.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.92. This value is below the healthy minimum of 20. It has increased from 12.38 (Mar 24) to 12.92, marking an increase of 0.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 76.62. This value exceeds the healthy maximum of 70. It has decreased from 77.27 (Mar 24) to 76.62, marking a decrease of 0.65.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.08. This value exceeds the healthy maximum of 70. It has decreased from 87.62 (Mar 24) to 87.08, marking a decrease of 0.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.99. This value is within the healthy range. It has decreased from 5.05 (Mar 24) to 3.99, marking a decrease of 1.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.10 (Mar 24) to 1.90, marking a decrease of 0.20.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,121.11. It has increased from 2,795.80 (Mar 24) to 3,121.11, marking an increase of 325.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.91, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 10.81. This value is within the healthy range. It has decreased from 11.56 (Mar 24) to 10.81, marking a decrease of 0.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.69, marking a decrease of 0.16.
- For Retention Ratios (%), as of Mar 25, the value is 76.61. This value exceeds the healthy maximum of 70. It has decreased from 77.26 (Mar 24) to 76.61, marking a decrease of 0.65.
- For Price / BV (X), as of Mar 25, the value is 3.05. This value exceeds the healthy maximum of 3. It has decreased from 3.34 (Mar 24) to 3.05, marking a decrease of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.69, marking a decrease of 0.16.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lumax Industries Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.3% (Industry Average ROCE: 20.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.06% (Industry Average ROE: 15.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 33 (Industry average Stock P/E: 56.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.99
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | 2nd Floor, Harbans Bhawan-II, New Delhi Delhi 110046 | lumaxshare@lumaxmail.com https://www.lumaxworld.in/lumaxindustries |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dhanesh Kumar Jain | Chairman Emeritus |
| Mr. Deepak Jain | Chairman & Managing Director |
| Mr. Anmol Jain | Joint Managing Director |
| Mr. Tadayoshi Aoki | Senior Executive Director |
| Mr. Raajesh Kumar Gupta | Executive Director |
| Mr. Kenjiro Nakazono | Executive Director |
| Mr. Tomohiro Kondo | Non Executive Director |
| Mr. Rajeev Kapoor | Independent Director |
| Ms. Ritika Sethi | Independent Director |
| Mr. Vikrampati Singhania | Independent Director |
| Mr. Harish Lakshman | Independent Director |
| Mr. Pradeep Singh Jauhar | Independent Director |
| Ms. Pallavi Dinodia Gupta | Independent Director |
FAQ
What is the intrinsic value of Lumax Industries Ltd?
Lumax Industries Ltd's intrinsic value (as of 29 October 2025) is 4248.36 which is 15.19% lower the current market price of 5,009.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,683 Cr. market cap, FY2025-2026 high/low of 5,358/1,960, reserves of ₹765 Cr, and liabilities of 2,861 Cr.
What is the Market Cap of Lumax Industries Ltd?
The Market Cap of Lumax Industries Ltd is 4,683 Cr..
What is the current Stock Price of Lumax Industries Ltd as on 29 October 2025?
The current stock price of Lumax Industries Ltd as on 29 October 2025 is 5,009.
What is the High / Low of Lumax Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Lumax Industries Ltd stocks is 5,358/1,960.
What is the Stock P/E of Lumax Industries Ltd?
The Stock P/E of Lumax Industries Ltd is 33.0.
What is the Book Value of Lumax Industries Ltd?
The Book Value of Lumax Industries Ltd is 828.
What is the Dividend Yield of Lumax Industries Ltd?
The Dividend Yield of Lumax Industries Ltd is 0.70 %.
What is the ROCE of Lumax Industries Ltd?
The ROCE of Lumax Industries Ltd is 16.4 %.
What is the ROE of Lumax Industries Ltd?
The ROE of Lumax Industries Ltd is 19.3 %.
What is the Face Value of Lumax Industries Ltd?
The Face Value of Lumax Industries Ltd is 10.0.